Usefulness of Fractional Flow Reserve to Predict Clinical Outcome After Balloon Angioplasty

Author:

Bech G. Jan Willem1,Pijls Nico H. J.1,De Bruyne Bernard1,Peels Kathinka H.1,Michels H. Rolf1,Bonnier Hans J. R. M.1,Koolen Jacques J.1

Affiliation:

1. From the Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands, and the Cardiovascular Center, Aalst, Belgium (B.D.B.).

Abstract

Background —After regular coronary balloon angioplasty, it would be helpful to identify those patients who have a low cardiac event rate. Coronary angiography alone is not sensitive enough for that purpose, but it has been suggested that the combination of optimal angiographic and optimal functional results indicates a low restenosis chance. Pressure-derived myocardial fractional flow reserve (FFR) is an index of the functional severity of the residual epicardial lesion and could be useful for that purpose. Methods and Results —In 60 consecutive patients with single-vessel disease, balloon angioplasty was performed by use of a pressure instead of a regular guide wire. Both quantitative coronary angiography (QCA) and measurement of FFR were performed 15 minutes after the procedure. A successful angioplasty result, defined as a residual diameter stenosis (DS) <50%, was achieved in 58 patients. In these patients, DS and FFR, measured 15 minutes after PTCA, were analyzed in relation to clinical outcome. In those 26 patients with both optimal angiographic (residual DS by QCA ≤35%) and optimal functional (FFR ≥0.90) results, event-free survival rates at 6, 12, and 24 months were 92±5%, 92±5%, and 88±6%, respectively, versus 72±8%, 69±8%, and 59±9%, respectively, in the remaining 32 patients in whom the angiographic or functional result or both were suboptimal ( P =0.047, P =0.028, and P =0.014, respectively). Conclusions —In patients with a residual DS ≤35% and FFR ≥0.90, clinical outcome up to 2 years is excellent. Therefore, there is a complementary value of coronary angiography and coronary pressure measurement in the evaluation of PTCA result.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3